FDx Advisors Inc. cut its holdings in Costco Wholesale Co. (NASDAQ:COST) by 45.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,380 shares of the retailer’s stock after selling 6,981 shares during the period. FDx Advisors Inc.’s holdings in Costco Wholesale were worth $1,751,000 at the end of the most recent reporting period.
Other large investors have also recently modified their holdings of the company. MUFG Securities EMEA plc bought a new position in shares of Costco Wholesale during the second quarter valued at about $103,000. Well Done LLC bought a new position in shares of Costco Wholesale during the first quarter valued at about $109,000. Smart Portfolios LLC bought a new position in shares of Costco Wholesale during the first quarter valued at about $113,000. Trilogy Capital Inc. bought a new position in shares of Costco Wholesale during the first quarter valued at about $116,000. Finally, Harvest Fund Management Co. Ltd raised its stake in shares of Costco Wholesale by 82.9% during the first quarter. Harvest Fund Management Co. Ltd now owns 737 shares of the retailer’s stock valued at $138,000 after acquiring an additional 334 shares during the last quarter. 72.19% of the stock is owned by hedge funds and other institutional investors.
Top Heal Care Stocks To Own For 2019: VALE S.A.(VALE)
Advisors' Opinion:- [By Neha Chamaria]
Wheaton first took the gold leap in 2013 when it struck an agreement with mining giant Vale (NYSE:VALE) to buy 25% of the gold produced from its Salobo mine in Brazil for the life of mine, as well as 70% of the gold produced from its Sudbury mines in Canada for a 20-year term. Wheaton paid $1.9 billion to Vale in addition to stock warrants for the deal.
- [By Shane Hupp]
Vale (NYSE:VALE) and Quaterra Resources (OTCMKTS:QTRRF) are both basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation and institutional ownership.
- [By Reuben Gregg Brewer]
Shares of Brazilian mining powerhouse Vale SA (NYSE:VALE) rose 11.6% in September, according to data provided by S&P Global Market Intelligence. The company's stock has experienced a series of sharp price advances and declines in 2018, but at the end of nine months, it was up roughly 21% for the year.
Top Heal Care Stocks To Own For 2019: Shore Bancshares Inc(SHBI)
Advisors' Opinion:- [By Shane Hupp]
Press coverage about Shore Bancshares (NASDAQ:SHBI) has been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Shore Bancshares earned a coverage optimism score of 0.15 on Accern’s scale. Accern also assigned news headlines about the bank an impact score of 46.3784121307224 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
- [By Joseph Griffin]
LSV Asset Management increased its stake in Shore Bancshares Inc (NASDAQ:SHBI) by 134.4% during the 1st quarter, Holdings Channel reports. The firm owned 157,489 shares of the bank’s stock after acquiring an additional 90,289 shares during the period. LSV Asset Management’s holdings in Shore Bancshares were worth $2,970,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Joseph Griffin]
Media coverage about Shore Bancshares (NASDAQ:SHBI) has trended somewhat positive on Sunday, Accern reports. The research firm rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Shore Bancshares earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media headlines about the bank an impact score of 47.376414932679 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Top Heal Care Stocks To Own For 2019: Gilead Sciences, Inc.(GILD)
Advisors' Opinion:- [By Chris Lange]
Gilead Sciences Inc. (NASDAQ: GILD) has a PDUFA date for its HIV-1 treatment, bictegravir in combination with emtricitabine/tenofovir alafenamide, set on February 12. Shares of Gilead were last seen at $85.46, with a consensus price target of $86.54 and a 52-week range of $70.05 to $85.49.
- [By Chris Lange]
Gilead Sciences Inc. (NASDAQ: GILD) will report its most recent quarterly results Wednesday afternoon. The consensus estimates for the second quarter call for EPS of $1.56 and $5.2 billion in revenue. The shares were last seen trading at $76.98, in a 52-week range of $64.27 to $89.54. The consensus price target is $86.00.
- [By George Budwell]
The immuno-oncology revolution kicked into high gear at the end of 2017, thanks to the back-to-back approvals for Gilead Sciences' (NASDAQ:GILD) and Novartis' (NYSE:NVS) respective cell-based cancer therapies. While these two regulatory approvals marked a watershed moment in the annals of immuno-oncology, the fact remains that this high-growth market still has a lot of growing up to do.
- [By Timothy Green, Demitrios Kalogeropoulos, Keith Speights, Neha Chamaria, and Rich Smith]
What stocks should you invest in? Five of our Motley Fool investors have some ideas. Here's why you should consider adding Gilead Sciences (NASDAQ:GILD), International Business Machines (NYSE:IBM), 3M Company (NYSE:MMM), SodaStream International (NASDAQ:SODA), and SolarEdge Technologies (NASDAQ:SEDG) to your portfolio in June.
Top Heal Care Stocks To Own For 2019: The Descartes Systems Group Inc.(DSGX)
Advisors' Opinion:- [By Max Byerly]
Descartes Systems Group (TSE:DSG) (NASDAQ:DSGX) had its target price lifted by Barclays from C$43.00 to C$45.00 in a research report report published on Thursday.
- [By Ethan Ryder]
Descartes Systems Group (NASDAQ:DSGX) (TSE:DSG) was upgraded by research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Thursday.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Descartes Systems Group (DSGX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Descartes Systems Group (NASDAQ:DSGX) (TSE:DSG) last issued its earnings results on Wednesday, November 28th. The technology company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.02). Descartes Systems Group had a return on equity of 5.88% and a net margin of 11.24%. The business had revenue of $70.00 million for the quarter, compared to analyst estimates of $69.69 million. During the same period last year, the business posted $0.08 EPS. Descartes Systems Group’s revenue was up 12.9% on a year-over-year basis. Equities analysts forecast that Descartes Systems Group Inc will post 0.41 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Mackenzie Financial Corp Purchases 278,713 Shares of Descartes Systems Group Inc (DSGX)” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/4163867/mackenzie-financial-corp-purchases-278713-shares-of-descartes-systems-group-inc-dsgx.html.About Descartes Systems Group
No comments:
Post a Comment